Clinical Trial Update: ALFAURUS : A DB Randomized Parallel Group Study of Alfuzosin 10mg OD vs Placebo in the Management of AUR in Patients With a 1st Episode Due to BPH [Phase 3]

View source ↗

Summary

Phase 3 randomized trial comparing alfuzosin 10 mg once daily to placebo for acute urinary retention due to benign prostatic hyperplasia; the study has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia
• Urinary Retention

Drugs mentioned

• Alfuzosin (alfuzosin)

Snippet

Sponsor: Sanofi | Conditions: Prostatic Hyperplasia, Acute Urinary Retention | Phase 3 | Status: COMPLETED